|
Age, years
|
55.2 ± 5.5
|
56.7 ± 5.6
|
0.029a
|
|
Time since menopause, years
|
4 (2–10)
|
7 (2–12)
|
0.157a
|
|
White participants, % (n)
|
88.6% (210)
|
85.1% (74)
|
0.503b
|
|
Waist circumference, cm (n = 292)c
|
|
WC < 88 cm
|
66.35% (140)
|
35.80% (29)
|
< 0.001b
|
|
WC ≥ 88 cm
|
33.65% (71)
|
64.20% (52)
|
|
Body mass index, kg/m2 (n = 287)c
|
|
< 24.9
|
41% (85)
|
17.50% (14)
|
< 0.001b
|
|
25–30
|
44% (91)
|
41.25% (33)
|
|
> 30
|
15% (31)
|
41.25% (33)
|
|
SBP, mmHg
|
125.8 ± 17.4
|
131.2 ± 19.3
|
0.021a
|
|
DBP, mmHg
|
79.7 ± 11.1
|
82.2 ± 11.7
|
0.084a
|
|
Total cholesterol, mg/dl
|
214.6 ± 41.9
|
212.2 ± 48.1
|
0.662a
|
|
HDL-c, mg/dl
|
58.3 ± 14.4
|
54.4 ± 11.8
|
0.030a
|
|
LDL-c, mg/dl
|
130.4 ± 36.3
|
126.5 ± 36.7
|
0.410a
|
|
Triglycerides, mg/dl
|
115 (76–157)
|
131 (97–173)
|
0.018a
|
|
Glucose, mg/dl
|
94.1 ± 24.8
|
93.4 ± 18.3
|
0.946a
|
|
HOMA-IR
|
1.6 (1.2–2.4)
|
2.1 (1.5–3.1)
|
0.026a
|
|
Insulin, μUI/ml
|
7.4 (5.5–10.1)
|
9.1 (6.6–13.2)
|
0.019a
|
|
Metabolic syndrome, % (n)
|
26.2% (62)
|
38.6% (34)
|
0.040b
|
|
IL6, pg/mL (n = 279)c
|
1.02 (0.73–1.56)
|
1.43 (1.08–2.44)
|
< 0.001a
|
|
HT, % (n)
|
32% (76)
|
21% (19)
|
0.082b
|
|
Oral (n = 54)c
|
65.7% (44)
|
52.6% (10)
|
0.442b
|
|
Non-oral (n = 32)c
|
34.3% (23)
|
47.4% (9)
|
|
T carriers, % (n)
|
65% (155)
|
48% (43)
|
0.008b
|